宫颈癌;流行病学;发病率;死亡率;防治," /> 宫颈癌;流行病学;发病率;死亡率;防治,"/> Cervical cancerEpidemiologyIncidence rateMortalityPrevention and cure,"/>  <span style="font-family:宋体;">全球及我国宫颈癌流行现状及防治策略</span><span style="font-family:'Times New Roman','serif';"></span>

临床肿瘤学杂志 ›› 2023, Vol. 28 ›› Issue (01): 90-93.

• 综述与讲座 • 上一篇    

 全球及我国宫颈癌流行现状及防治策略

  

  1.  150081  哈尔滨  哈尔滨医科大学肿瘤防治研究所
  • 收稿日期:2022-06-24 修回日期:2022-10-19 出版日期:2023-01-31 发布日期:2023-03-08
  • 通讯作者: 孙惠昕 E-mail::6666901@163.com
  • 基金资助:
    2021年度省自然科学基金优秀青年项目(YQ2021H021

Prevalence and prevention strategies of cervical cancer in the world and China

  1. Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin 150081
  • Received:2022-06-24 Revised:2022-10-19 Online:2023-01-31 Published:2023-03-08

摘要: 国际癌症研究中心(IARC)通过GLOBOCAN 2020数据库估计了全球185个国家/地区的36种癌症发病率和死亡率。GLOBOCAN 2020数据库显示,宫颈癌无论是发病病例还是死亡病例,均为全球女性第四大肿瘤,宫颈癌对女性健康的危害及防治是全世界面临的重要公共卫生问题。本文将从人群特征、地区分布、时间变化趋势等方面汇总和比较全球及中国宫颈癌的发病和死亡流行现状,并结合目前已报道的人乳头瘤病毒等宫颈癌危险因素、一级预防和二级预防策略,以期为今后宫颈癌的防治策略提供科学线索。

关键词: 宫颈癌;流行病学;发病率;死亡率;防治">宫颈癌;流行病学;发病率;死亡率;防治')">">

Abstract:  The International Agency for Research on Cancer (IARC) estimates 36 cancer incidence rate and mortality rates in 185 countries/regions through GLOBOCAN 2020 database. Globocan2020 database shows that cervical cancer is the fourth largest tumor in women in the world, whether it is morbidity or mortality. The harm of cervical cancer to women's health and its prevention and treatment are important public health issues facing the world. This paper will summarize and compare the incidence and death prevalence of cervical cancer in the world and China from the aspects of population characteristics, regional distribution and time change trend, and combined with the reported human papillomavirus and other risk factors, primary prevention and secondary prevention strategies of cervical cancer, in order to provide scientific clues for the prevention and treatment strategies of cervical cancer in the future.

Key words: font-size:10.5pt, Cervical cancer">Cervical cancerfont-size:10.5pt, ">;font-size:10.5pt, Epidemiology">Epidemiologyfont-size:10.5pt, ">;font-size:10.5pt, Incidence rate">Incidence ratefont-size:10.5pt, ">;font-size:10.5pt, Mortality">Mortalityfont-size:10.5pt, ">;font-size:10.5pt, Prevention and cure')">">Prevention and cure

中图分类号: 

  •  
[1] 梁宗英, 赵宝山, 郑竞雄, 侯继申, 孙光蕊. 乙酰基转移酶KAT2ASurvivin蛋白乙酰化在食管癌中的相关性研究[J]. 临床肿瘤学杂志, 2023, 28(01): 16-22.
[2] 邱思冲, 徐禄玉, 李柳宁.  基于SEER数据库恶性脑膜瘤预后列线图的构建与验证[J]. 临床肿瘤学杂志, 2023, 28(01): 30-37.
[3] 占天鹏, 何魏, 张勐, 陶燕, 卢建中, 付生军, 李兰兰, 张静, 刘善辉.  UBE2C基因在肾透明细胞癌中的临床预后价值及分子机制探究[J]. 临床肿瘤学杂志, 2023, 28(01): 49-57.
[4] 薛璐昕, 张志凡, 刘芳岑, 王晓露, 王琴, 刘宝瑞, 李茹恬.  免疫检查点抑制剂在软组织肉瘤中的应用:现状与展望[J]. 临床肿瘤学杂志, 2023, 28(01): 77-83.
[5] 刘德龙, 蒋穗斌, 郭东铭. MALAT1靶向调控miR-205与骨肉瘤侵袭的实验研究[J]. 临床肿瘤学杂志, 2018, 23(5): 385-390.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!